Evolving CLL Therapy: The Power of Doublet and Triplet Regimens

from Medical News Podcast · host PeerDirect Publishing

John N. Allan, MD and Andrew H. Lipsky, MD discuss the evolution of CLL therapy and the power of doublet and triplet regimens, exploring combinations including BTK inhibitors with BCL-2 inhibitors and anti-CD20 monoclonal antibodies.

Episode metadata supplied by the publisher feed · Published Jun 10, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Evolving CLL Therapy: The Power of Doublet and Triplet Regimens

0:00 10:38

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 10 minutes long.

When was this Medical News Podcast episode published?

This episode was published on June 10, 2025.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!